Mental Health Clinics in Ridgway, CO Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Source Counseling Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 177 Sherman Street #101, Balance Natural Medicine, Ridgway, CO 81432 Phone: 970-729-0862 |
Mindfulness Based Interventions Llc Clinic - Adult Mental Health Medicare: Medicare Enrolled Practice Location: 380 Sherman St, Ridgway, CO 81432 Phone: 970-318-0529 Fax: 855-403-3931 |
Southwest Colorado Mental Health Center Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 112 Village Sq W Ste 201, Ridgway, CO 81432 Phone: 970-252-3200 Fax: 970-626-4255 |
Mindfulness Based Interventions Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 380 Sherman St, Ridgway, CO 81432 Phone: 970-318-0529 Fax: 855-403-3931 |
Mountain Family Living, A Prof Corp Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 167 N Cora, Ste 2, Ridgway, CO 81432 Phone: 970-626-4202 |
Mindfulness Based Interventions Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 255 Hunter Parkway, Ridgway, CO 81432 Phone: 970-318-0529 Fax: 855-403-3931 |
Mindfulness Based Interventions Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 640 Sherman St., Unit H, Ridgway, CO 81432 Phone: 970-318-0529 Fax: 855-403-3931 |
News Archive
Pfizer, Avon Foundation for Women reveal Avon-Pfizer Metastatic Breast Cancer Grants Program recipients
Today, Pfizer Inc. and the Avon Foundation for Women are proud to announce the first-ever recipients of the Avon-Pfizer Metastatic Breast Cancer Grants Program: Identify-Amplify-Unify.
NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for celiac disease
Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), to support the development of a novel antibody therapeutic for celiac disease.
AHF applauds Gilead for offering pricing, access concessions to AIDS Drug Assistance Programs
AIDS Healthcare Foundation (AHF) lauded Gilead Sciences, maker of several key AIDS drugs, for its announcement earlier today that it will offer significant pricing and access concessions for the nation's beleaguered AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.
SARS-CoV-2 Spike may trigger production of antibodies that cross-react with human thrombopoietin to induce thrombocytopenia
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infected individuals often suffer from thrombocytopenia, a condition associated with low platelet counts. The cytokine thrombopoietin regulates platelet count. Previous studies have reported that thrombocytopenia can increase the coronavirus disease 2019 (COVID-19) mortality rate by about five times.
Odor alters how memories are processed in the brain, research reveals
In a new paper published in Learning and Memory, researchers from Boston University's Center for Systems Neuroscience reveal just how much power scents have in triggering the memory of past experiences-and the potential for odor to be used as a tool to treat memory-related mood disorders.
› Verified 7 days ago